Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Sonoma Pharmaceuticals Inc (SNOA)

Sonoma Pharmaceuticals Inc (SNOA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sonoma Pharmaceuticals Inc 645 MOLLY LANE SUITE 150 WOODSTOCK GA 30189 USA

P: 800-759-9305

Description:

Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus Innovative Sciences and is headquatered in Petaluma, California.

Key Statistics

Overview:

Market Capitalization, $K 11,184
Shares Outstanding, K 2,092
Annual Sales, $ 18,630 K
Annual Net Income, $ -3,950 K
Last Quarter Sales, $ 3,680 K
Last Quarter Net Income, $ -1,100 K
60-Month Beta 0.77
% of Insider Shareholders 6.60%
% of Institutional Shareholders 10.11%
Float, K 1,954
% Float 93.40%

Growth:

1-Year Return -37.79%
3-Year Return -66.98%
5-Year Return -85.85%
5-Year Revenue Growth 23.54%
5-Year Earnings Growth 91.58%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/13/21
Earnings Per Share ttm -2.40
EPS Growth vs. Prev Qtr 68.29%
EPS Growth vs. Prev Year -2,700.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-9 on 06/20/19

SNOA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -0.71
Price/Earnings to Growth N/A
Return-on-Equity % -59.12%
Return-on-Assets % -30.57%
Profit Margin % -21.20
Net Margin % N/A
Debt/Equity 0.24
Price/Sales 0.61
Price/Cash Flow N/A
Price/Book 2.70
Book Value/Share 2.21
Interest Coverage -389.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar